CYTOKINETICS INCORPORATED - COMMON STOCK
49.10
22-十一月-24 16:44:58
15 分钟延时
股票
+1.43
+3.00%
今日范围
47.41 - 49.82
ISIN
N/A
来源
NASDAQ
-
Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan
19 11月 2024 02:30:00 条件 Nasdaq GlobeNewswire
-
16 11月 2024 09:00:00 条件 Nasdaq GlobeNewswire
-
16 11月 2024 09:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference
12 11月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089
11 11月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Reports Third Quarter 2024 Financial Results
06 11月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
05 11月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 11月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics to Announce Third Quarter Results on November 6, 2024
23 10月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
16 10月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 10月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics to Host Investor & Analyst Day on October 16, 2024
02 10月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting
30 9月 2024 09:20:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions
27 9月 2024 11:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Announces Call for Proposals for Its Seventh Annual Communications Grant Program
24 9月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
19 9月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Announces Data From Phase 1 Study of CK-4021586
09 9月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
05 9月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 9月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
01 9月 2024 04:27:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >